Detailed Information

Cited 39 time in webofscience Cited 42 time in scopus
Metadata Downloads

Single-stranded DNA aptamer that specifically binds to the influenza virus NS1 protein suppresses interferon antagonism

Authors
Woo, Hye-MinKim, Ki-SunLee, Jin-MooShim, Hee-SupCho, Seong-JeLee, Won-KyuKo, Hyuk WanKeum, Young-SamKim, Soo-YoulPathinayake, PrabuddhaKim, Chul-JoongJeong, Yong-Joo
Issue Date
Nov-2013
Publisher
ELSEVIER SCIENCE BV
Keywords
Influenza virus; NS1; Aptamer; Interferon; G-quadruplex
Citation
ANTIVIRAL RESEARCH, v.100, no.2, pp 337 - 345
Pages
9
Indexed
SCI
SCIE
SCOPUS
Journal Title
ANTIVIRAL RESEARCH
Volume
100
Number
2
Start Page
337
End Page
345
URI
https://scholarworks.dongguk.edu/handle/sw.dongguk/15417
DOI
10.1016/j.antiviral.2013.09.004
ISSN
0166-3542
1872-9096
Abstract
Non-structural protein 1 (NS1) of the influenza A virus (IAV) inhibits the host's innate immune response by suppressing the induction of interferons (IFNs). Therefore, blocking NS1 activity can be a potential strategy in the development of antiviral agents against IAV infection. In the present study, we selected a single-stranded DNA aptamer specific to the IAV NS1 protein after 15 cycles of systematic evolution of ligands by exponential enrichment (SELEX) procedure and examined the ability of the selected aptamer to inhibit the function of NS1. The selected aptamer binds to NS1 with a K-d of 18.91 +/- 3.95 nM and RNA binding domain of NS1 is determined to be critical for the aptamer binding. The aptamer has a G-rich sequence in the random sequence region and forms a G-quadruplex structure. The localization of the aptamer bound to NS1 in cells was determined by confocal images, and flow cytometry analysis further demonstrated that the selected aptamer binds specifically to NS1. In addition, luciferase reporter gene assay, quantitative RT-PCR, and enzyme-linked immunosorbent assay (ELISA) experiments demonstrated that the selected aptamer had the ability to induce IFN-beta by suppressing the function of NS1. Importantly, we also found that the selected aptamer was able to inhibit the viral replication without affecting cell viability. These results indicate that the selected ssDNA aptamer has strong potential to be further developed as a therapeutic agent against IAV. (C) 2013 Elsevier B.V. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Pharmacy > Department of Pharmacy > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Keum, Young Sam photo

Keum, Young Sam
College of Pharmacy (Department of Pharmacy)
Read more

Altmetrics

Total Views & Downloads

BROWSE